Genincode Plc Logo

Genincode Plc (GENI)

LSE

Currency in GBp
1.02
+0.07 (+7.89%)

Real-time Data

07:00 AM

Day's Range

0.9000
1.10

52 wk Range

0.7500
5.50

Profile - GENI - Genincode Plc

Profile

Mic Code

AIMX

Sector

Healthcare

Industry

Diagnostics & Research

Employees

44


Genincode Plc is a biotechnology company specializing in the development and commercialization of advanced predictive genetic testing solutions. The primary function of Genincode Plc is to provide innovative and personalized healthcare solutions that focus on cardiovascular disease risk assessment. Through its cutting-edge genetic testing technologies, the company aims to offer healthcare providers and patients insights into genetic predispositions, thereby facilitating tailored medical interventions and lifestyle recommendations. Genincode Plc has a significant impact on the biotechnology and personalized medicine sectors, driving advancements in early detection and prevention strategies for cardiovascular diseases. The company's market role is vital as it addresses growing demands for personalized healthcare solutions that improve therapeutic outcomes and optimize resource allocation within the healthcare system. Operating in the UK and beyond, Genincode Plc collaborates with various healthcare institutions to expand access to its genetic testing services, reinforcing its commitment to the evolution of precision medicine.

Profile Details

Type

Common Stock

Ceo

Mr. Matthew Heaton Walls

Address

One St. Peters Square

City

Manchester

Zip

M2 3DE

Country

United Kingdom

Phone

44 1865 676 125

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.